Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02248740 · ClinicalTrials.gov registry record · Phase 4

Radiofrequency Ablation vs. Laser Ablation of the Incompetent Small Saphenous Vein

A Phase 4 study, sponsored by Virginia Commonwealth University.

Terminated
Registry status
Phase 4
Development phase
36
Enrollment target

NCT02248740: Clinical Trial Phase 4 study, sponsored by Virginia Commonwealth University.

NCT02248740 is a Phase 4 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 36 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02248740, a Phase 4 study, was terminated before completion, sponsored by Virginia Commonwealth University.

TERMINATED
Registry status
Phase 4
Development phase
36 participants
Enrollment target

Study Summary

The aim of this study is to perform a randomized, prospective trial comparing the two current methods of treatment for chronic venous insufficiency related to the Small Saphenous Vein (SSV) to evaluate complications and outcomes for each method, and ultimately, to see if one is superior to the other.

Interventions

  • PROCEDURE Ablation of the incompetent small saphenous vein

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2008-09
Est. Completion 2017-03-29
Phase Phase 4
Virginia Commonwealth University

558 total trials

Why NCT02248740 stopped before completion

NCT02248740 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Ablation of the incompetent small saphenous vein is the first listed.

NCT02248740 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02248740 about?

NCT02248740 is a clinical study titled "Radiofrequency Ablation vs. Laser Ablation of the Incompetent Small Saphenous Vein". The aim of this study is to perform a randomized, prospective trial comparing the two current methods of treatment for chronic venous insufficiency related to the Small Saphenous Vein (SSV) to evaluate complications and outcomes for each method, and ultimately, to see if one is superior to the other...

What is the current status of trial NCT02248740?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2008-09. Estimated completion is 2017-03-29.

What interventions are being tested in trial NCT02248740?

The interventions under investigation include: Ablation of the incompetent small saphenous vein (PROCEDURE).

Who is sponsoring clinical trial NCT02248740?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02248740's enrollment target sits among peer trials

36 1490th of 2000 higher than 495 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02248740, the US trial registry maintained by the National Library of Medicine. NCT02248740 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.